Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.

RPEP-071202023Lincoff, A Michael; Brown-Frandsen, Kirstine; Colhoun, Helen M; Deanfield, John; Emerson, Scott S; Esbjerg, Sille; Hardt-Lindberg, Søren; Hovingh, G Kees; Kahn, Steven E; Kushner, Robert F; Lingvay, Ildiko; Oral, Tugce K; Michelsen, Marie M; Plutzky, Jorge; Tornøe, Christoffer W; Ryan, Donna H

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.

The New England journal of medicine, 389(24), 2221-2232

View on PubMed ↗Publisher’s paper ↗

Citation

Lincoff, A Michael; Brown-Frandsen, Kirstine; Colhoun, Helen M; Deanfield, John; Emerson, Scott S; Esbjerg, Sille; Hardt-Lindberg, Søren; Hovingh, G Kees; Kahn, Steven E; Kushner, Robert F; Lingvay, Ildiko; Oral, Tugce K; Michelsen, Marie M; Plutzky, Jorge; Tornøe, Christoffer W; Ryan, Donna H. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.. The New England journal of medicine, 389(24), 2221-2232. https://doi.org/10.1056/NEJMoa2307563